University of Pittsburgh-ko ikertzaileekin lankidetzan egindako argitalpenak (57)

2024

  1. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

    JHEP Reports, Vol. 6, Núm. 1

  2. Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 3

2023

  1. Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis (Nature Communications, (2019), 10, 1, (3126), 10.1038/s41467-019-11004-3)

    Nature Communications

  2. Rescue of infant progressive familial intrahepatic cholestasis type 3 mice by repeated dosing of AAV gene therapy

    JHEP Reports, Vol. 5, Núm. 5

2022

  1. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268

  2. Poor Outcomes of Patients With NAFLD and Moderate Renal Dysfunction or Short-Term Dialysis Receiving a Liver Transplant Alone

    Transplant International, Vol. 35

2021

  1. An Experimental DUAL Model of Advanced Liver Damage

    Hepatology Communications, Vol. 5, Núm. 6, pp. 1051-1068

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Ethical criteria for the admission and management of patients in the icu under conditions of limited medical resources: A shared international proposal in view of the covid-19 pandemic

    Frontiers in Public Health, Vol. 8

  2. Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH

    Cells, Vol. 9, Núm. 5

  3. Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 117, Núm. 21

  4. Isn’t the evidence base for pediatric bipolar disorder already sufficient to inform clinical practice?

    Bipolar Disorders, Vol. 22, Núm. 7, pp. 664-665

  5. Oral contraceptives use and development of obesity in a Mediterranean cohort: the SUN (Seguimiento Universidad de Navarra) Project

    International Journal of Obesity, Vol. 44, Núm. 2, pp. 320-329

  6. Recent advances in alcohol-related liver disease (ALD): Summary of a Gut round table meeting

    Gut, Vol. 69, Núm. 4, pp. 764-780

2019

  1. Adherence to the Mediterranean diet and risk of stroke and stroke subtypes

    European Journal of Epidemiology, Vol. 34, Núm. 4, pp. 337-349

  2. Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide

    Clinical Gastroenterology and Hepatology, Vol. 17, Núm. 11, pp. 2320-2329.e12

  3. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis

    Nature Communications, Vol. 10, Núm. 1

  4. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis [Suppl Data]

    Zenodo

  5. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis [Suppl Data]

    Zenodo